Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer
NCT04733118
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
393
Enrollment
OTHER
Sponsor class
Conditions
Early Breast Cancer
Interventions
DRUG:
Trastuzumab and Pertuzumab (FDC SC) and T-DM1
Sponsor
MedSIR
Collaborators
[object Object]